Chad Beyer, Ph.D., MBA is Senior Vice President of Research and Development at Promentis. He has over 20 years of experience in the research, discovery and development of medications aimed to treat CNS and neurological disorders. Prior to joining Promentis, Beyer served as the Head of Neurochemistry and led the Psychiatry Task Force at Wyeth Pharmaceuticals in Princeton, NJ. During his career at Wyeth, Beyer led several early-stage drug discovery teams and managed a group responsible for contributing to the commercialization and life-cycle management of two blockbuster medications.
Interested in Biotechnology and Innovation?
Email the Dyer Center at email@example.com and schedule an appointment with Beyer. He is teaching INDS 246: Biotechnology and Innovation, which examines the commercialization of new life science technologies and discusses the roles of intellectual property, governmental policies, marketplace economics, and ethical debates in the process.